Naples Global Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Naples Global Advisors’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,000	Closed	-$243K	–	407
2024 Q4	$243K	Hold	2,000	–	–	0.02%	369
2024 Q3	$250K	Hold	2,000	–	–	0.02%	368
2024 Q2	$316K	Hold	2,000	–	–	0.03%	333
2024 Q1	$259K	Buy	+2,000	New	+$245K	0.03%	362
2023 Q4	–	Sell	-2,000	Closed	-$242K	–	419
2023 Q3	$242K	Hold	2,000	–	–	0.03%	360
2023 Q2	$229K	Hold	2,000	–	–	0.03%	369
2023 Q1	$276K	Hold	2,000	–	–	0.03%	345
2022 Q4	$259K	Hold	2,000	–	–	0.03%	347
2022 Q3	$221K	Buy	+2,000	New	+$202K	0.03%	351
2021 Q1	–	Sell	-2,000	Closed	-$341K	–	373
2020 Q4	$341K	Hold	2,000	–	–	0.06%	288
2020 Q3	$281K	Hold	2,000	–	–	0.05%	289
2020 Q2	$321K	Buy	+2,000	New	+$272K	0.07%	269
2020 Q1	–	Sell	-2,000	Closed	-$258K	–	333
2019 Q4	$258K	Buy	+2,000	New	+$202K	0.05%	286
2019 Q3	–	Sell	-2,000	Closed	-$304K	–	319
2019 Q2	$304K	Hold	2,000	–	–	0.07%	261
2019 Q1	$238K	Hold	2,000	–	–	0.06%	272
2018 Q4	$237K	Hold	2,000	–	–	0.07%	269
2018 Q3	$323K	Hold	2,000	–	–	0.09%	249
2018 Q2	$264K	Buy	+2,000	New	+$189K	0.07%	266

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Naples Global Advisors's SRPT Position: Q1 2025 in Review

Naples Global Advisors sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,000 shares — an estimated $243K sold.

Naples Global Advisors first reported a position in SRPT in Q2 2018 and held it in 18 quarters. The position peaked at $341K in Q4 2020. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

Naples Global Advisors reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
Naples Global Advisors sold 2,000 Sarepta Therapeutics shares in Q1 2025, an estimated $243K.
Naples Global Advisors first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 18 quarters.
Naples Global Advisors's Sarepta Therapeutics position peaked at $341K in Q4 2020.
430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Naples Global Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.